AI Science Tracker

University of North Carolina at Chapel Hill

2 discoveries from 2021 to 2024

Discoveries

FRASE-bot screening identifies a small-molecule ligand that selectively kills CIB1-dependent cancer cells

FRASE-bot used a neural-network nativeness score to triage protein–ligand fragments, then used the retained structural features to seed virtual screening for Calcium and Integrin Binding Protein 1 (CIB1). Of 56 purchased virtual-screen hits, 29 showed dose-dependent CIB1 displacement; compound UNC10245380 (UNC5380) had a TR-FRET displacement IC50 of 8.0 ± 2.5 μM and selectively killed CIB1-depletion-sensitive triple-negative breast cancer cells in the reported assays, with no detected killing in an insensitive line.

Technology: FRASE-bot: fragment-in-structural-environment screening with a neural-network nativeness scoring model

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: Of 56 purchased virtual-screen hits, 29 showed dose-dependent CIB1 displacement; compound UNC10245380 (UNC5380) had a TR-FRET displacement IC50 of 8.0 ± 2.5 μM and selectively killed CIB1-depletion-sensitive triple-negative breast cancer cells in the reported assays, with no detected killing in an insensitive line.
  • Still unknown: The authors describe UNC10245380 as a starting chemical probe/lead, not a drug. Binding was inferred from peptide displacement in TR-FRET and a docking pose; the pose is not a solved small-molecule complex. Selective cell killing was in vitro at 30 μM, with no animal or clinical evidence. The earlier Research Square manuscript is the same underlying paper/result and is not counted separately.
  • AI role: The neural network triaged fragments by predicted native-ligand pose likelihood; selected fragments informed pharmacophore construction and virtual screening. The resulting purchased compounds were then tested in TR-FRET binding-displacement and cell-death assays. The model did not perform the wet-lab validation.

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11219766/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: at percentile 86 of works of the same type, year and subfield (OpenAlex work metrics, 14 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Machine learning guides automated synthesis of 19F MRI copolymer agents

An automated continuous-flow polymer platform synthesized 397 copolymer compositions in a six-variable space, in iterative cycles guided by machine learning. Exploring under 0.9% of the compositional space, the models identified more than ten copolymers that outperformed state-of-the-art 19F MRI agents. Validation is experimental across hundreds of real syntheses, but the imaging performance claims are limited to the compositions tested.

Technology: Machine learning models guiding automated flow copolymer synthesis

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: An automated flow-synthesis platform made 397 copolymer compositions in a six-variable space; 10 compositions outperformed state-of-the-art 19F MRI agents.
  • Still unknown: In vivo imaging performance is not reported in the abstract.
  • AI role: Machine learning guided iterative synthesis cycles and identified non-intuitive design criteria.

Evidence sources: https://doi.org/10.1021/jacs.1c08181

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 10% of works of the same type, year and subfield (OpenAlex work metrics, 165 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 4/5 · Validation 3/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open the interactive profile for the timeline, or browse all organizations and model families.